The CEO's sales are mechanically tied to option exercises and follow a pattern seen in prior periods, not a fresh bearish signal. The dollar amount is trivial relative to market cap. No actionable trading signal from this cluster alone. Monitor the next 10-Q for any fundamental deterioration that would justify a more cautious stance.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 2 $70.15entry
- T+1 · 6mo ago +3.11%α +3.80% · $72.33
- T+5 · 5mo ago −0.13%α +2.84% · $70.06
- T+20 · 5mo ago +45.76%α +47.32% · $102.25
- T+60 · 3mo ago +113.91%α +112.80% · $150.06
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A cluster of insider selling at Twist Bioscience over the past week, led by CEO Emily Leproust who sold ~$3.2M in open-market shares alongside option exercises, while the CAO and a director also sold smaller amounts. The total open-market sales of ~$4.0M represent ~0.1% of the $4.2B market cap, falling at the low end of the proportionality band. The CEO's sales are part of a regular pattern tied to option exercises, reducing their informational signal per the academic literature.
Key Financial Metrics
Key Facts
- CEO Emily Leproust sold 49,516 shares open-market for ~$3.2M across May 26-28, all tied to same-day option exercises at $8.82 or $0 strike
- CAO Robert Werner sold 800 shares for ~$50K on May 26
- Director Melissa Starovasnik sold 3,000 shares for ~$201K across May 26 and May 28
- Total open-market sales in the cluster: ~$4.0M, or ~0.1% of market cap
- Non-cash option exercises (M transactions) by CEO totaled $0 economic value for 65,769 shares
- Prior 30-day insider activity showed 5 sells totaling $3.4M, consistent with ongoing selling pattern
Financial Impact
Total open-market sales of ~$4.0M, representing ~0.1% of $4.2B market cap
Risk Factors
- CEO selling alongside option exercises could be misinterpreted as bearish by the market
- If the company reports disappointing earnings in the next quarter, the insider sales may be viewed in hindsight as informed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TWST-1780344427670 |
Track record
47 reports on TWST
8 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 10 of 12 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $105.04 +0.01% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $105.04 −0.11% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $105.04 +0.06% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $105.04 −0.54% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $105.04 +0.98% settles Dec 15
- Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $105.04 −8.04% settles Dec 11
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $105.04 −8.04% settles Dec 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $105.04 −20.50% settles Dec 9
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $105.04 −13.04% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $105.04 −12.91% settles Dec 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers